December 19, 2025 - 23:35

Ariana Aboulafia recently engaged with various experts to explore the ramifications of former President Trump’s policies on the academic landscape, particularly concerning the intersection of technology and disability rights. Scholars are increasingly concerned that these policies have fostered an environment where critical discussions about technology's societal implications are stifled.
Experts argue that the chilling effect on academic inquiry could hinder advancements in understanding how technology can both empower and marginalize individuals with disabilities. The lack of robust dialogue may lead to missed opportunities in developing inclusive technologies that cater to diverse needs.
Furthermore, the current political climate may discourage researchers from pursuing studies that challenge prevailing narratives or advocate for marginalized communities. As the field evolves, it is crucial for educators and policymakers to prioritize open discussions that promote equity and accessibility in technology, ensuring that the voices of those with disabilities are heard and respected in the ongoing discourse.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...